Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-07-19
2005-07-19
Aulakh, Charanjit S. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S210000, C546S209000, C546S231000, C514S331000
Reexamination Certificate
active
06919356
ABSTRACT:
The present application describes modulators of chemokine receptors of formula (I):or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
REFERENCES:
patent: 5621010 (1997-04-01), Sueda et al.
patent: 5668151 (1997-09-01), Poindexter et al.
patent: 5753654 (1998-05-01), Kikuchi et al.
patent: 5973160 (1999-10-01), Poss et al.
patent: 6136827 (2000-10-01), Caldwell et al.
patent: 6166015 (2000-12-01), Rogers et al.
patent: 6339087 (2002-01-01), Gong et al.
patent: 6441001 (2002-08-01), Watson et al.
patent: 6515151 (2003-02-01), Poss et al.
patent: 6521592 (2003-02-01), Ko et al.
patent: 2002/0094989 (2002-07-01), Hale et al.
patent: 625507 (1997-07-01), None
patent: 903349 (1999-03-01), None
patent: 2007808 (1989-07-01), None
patent: 4208267 (1992-07-01), None
patent: 2003155285 (2003-05-01), None
patent: WO 94/22846 (1994-10-01), None
patent: WO 95/13069 (1995-05-01), None
patent: WO 97/27752 (1997-08-01), None
patent: WO 97/38665 (1997-10-01), None
patent: WO 98/18761 (1998-05-01), None
patent: WO 98/25604 (1998-06-01), None
patent: WO 99/04794 (1999-02-01), None
patent: WO 00/35451 (2000-06-01), None
patent: WO 00/55143 (2000-09-01), None
patent: WO 00/59497 (2000-10-01), None
patent: WO 00/76512 (2000-12-01), None
patent: WO 00/76973 (2000-12-01), None
patent: WO 01/68604 (2001-09-01), None
patent: WO 01/98269 (2001-12-01), None
patent: WO 02/00676 (2002-01-01), None
patent: WO 02/18335 (2002-03-01), None
patent: WO 02/26723 (2002-04-01), None
patent: WO 02/083134 (2002-10-01), None
patent: WO 03/015717 (2003-02-01), None
patent: WO 03/070242 (2003-08-01), None
patent: WO 03/082291 (2003-10-01), None
patent: 03/086394 (2003-10-01), None
Shey et al., “Liquid Phase Combinatorial Synthesis of Benzylpiperazines”,Bioorganic&Medicinal Chemistry Letters,vol. 9, 1999, pp. 519-522.
Mayer et al., “New Substituted 1-(2,3-Dihydrobenzo[1,4]dioxin-2-ylmethyl)piperidin-4-yl Derivatives with αs-Adrenoceptor Antagonist Activity”,J. Med. Chem.,2000, vol. 43, pp. 3653-3664.
Database CAPLUS on STN No. 136:37522, “Preparation of piperidines as orexin receptor antagonists”, abstract, Branch et al., Feb. 2002.
Aulakh Charanjit S.
Bristol Myers Squibb Company
VanAtten Mary
LandOfFree
N-substituted heterocyclic amines as modulators of chemokine... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-substituted heterocyclic amines as modulators of chemokine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-substituted heterocyclic amines as modulators of chemokine... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3377682